DiNardo, C., Rodríguez-Arbolí, E., Esteve, J., Salamero, O., Brunner, A., Calbacho, M., Deangelo, D., Purroy, N., Limones, J., Jimenez, C., Hu, H., McTume, G., Jimenez, M. D., Estrada, J., Qian, Y., Carrancio, S., Prebet, T., Campbell, T. B., Pourdehnad, M., Uy, G. (2025). BMS-986397, a first-in-class casein kinase 1α (CK1α) degrader in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS): A phase 1 dose escalation study. Blood. https://doi.org/10.1182/blood-2025-1642